Craft

PhoenixBio

Stock Price

¥425

2024-10-29

Market Capitalization

¥1.7 B

2024-10-29

Revenue

¥1.5 B

FY, 2025

PhoenixBio Summary

Company Summary

Overview
PhoenixBio (株式会社フェニックスバイオ) is a company that provides contract study services for drug discovery and development. It offers PXB-cells, a human fatty liver cell optimized for lipid analysis; and PXB-mouse, a chimeric mouse with a humanized liver for use in drug development experiments.
Type
Public
Status
Active
Founded
2002
HQ
Higashihiroshima, JP | view all locations
Website
https://phoenixbio.co.jp
Cybersecurity rating
Sectors

LocationsView all

2 locations detected

  • Higashihiroshima, Hiroshima HQ

    Japan

    3-chōme-4-1 Kagamiyama

  • New York, NY

    United States

    65 Broadway # 605

PhoenixBio Financials

Summary Financials

Revenue (Q3, 2026)
¥1.2B
Gross profit (Q3, 2026)
¥953.1M
Net income (Q3, 2026)
¥93.2M
Cash (Q3, 2026)
¥1.1B
EBIT (Q3, 2026)
¥72.9M
Enterprise value
$966.3M

Footer menu